Company Analysis

Aytu BioPharma, Inc. (AYTU)

Nasdaq: AYTU · Pharmaceutical Preparations · Denver, CO · filing with the SEC since 2007
Grade4.2
◀ Past 3.5● Present 5.3▶ Future 3.5
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020FY 2018FY 2017
Period endingJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017
Report filedSep 22, 2026Sep 23, 2025Sep 26, 2024Oct 12, 2023Sep 27, 2022Sep 28, 2021Oct 6, 2020Sep 26, 2019Sep 6, 2018Aug 31, 2017
Revenue57,570,00066,382,00065,183,000r107,399,00096,669,00065,632,00027,632,0007,320,3573,660,1203,221,590
Cost of revenue20,752,00020,551,00016,129,000r40,767,00044,386,00036,432,0008,281,000r2,202,0412,050,5441,417,355
Gross profit36,818,00045,831,00049,054,000r66,632,00052,283,00029,200,00019,351,000···
Research and development01,326,0002,769,000r4,095,00012,662,000r5,623,0001,722,000r589,072167,595959,857
Selling, general and administrative······34,802,43218,887,78317,732,49017,442,627
Sales and marketing23,369,00020,906,00022,083,000r41,448,00038,713,00030,308,00011,403,000···
General and administrative19,272,00017,379,00019,954,000r28,630,00031,167,00025,500,00019,657,000···
Total operating expenses45,133,00053,658,00050,645,000r83,697,000162,189,000r88,070,00040,482,000r24,166,99423,360,35423,346,826
Operating income-8,315,000-7,827,000-1,591,000r-17,065,000-109,906,000r-58,870,000-21,131,000r-16,846,637-19,700,234-20,125,236
Interest expense1,895,0003,703,0005,059,000r4,963,000900,000·2,606,487535,500749,4232,534,358
Other income (expense), net713,000-512,000870,000r184,000r-757,000r-2,050,000-2,606,00080,7793,983,921·
Total non-operating income (expense)···14,0001,017,000r840,0007,510,000r-10,285,2719,512,371-2,383,068
Income before income taxes-14,231,000-13,745,000-10,378,000r-17,051,000-108,889,000r-58,030,000-13,621,000···
Income tax expense21,000437,0002,142,000r0-110,000259,0000000
Income from continuing operations-14,252,000-14,182,000-12,520,000·······
Income from discontinued operations0620,000-3,324,000·······
Net income including non-controlling interests···-17,051,000-108,779,000r-58,289,000-13,621,000···
Net income-14,252,000-13,562,000-15,844,000-17,051,000-108,779,000r-58,289,000-13,621,000r-27,131,908-10,187,863-22,508,304
Earnings per share, basic-1.16-2.16-2.86-5.11-74.01r-3.48····
Earnings per share, diluted···-5.11-74.01r-3.48····
Earnings per share, basic and diluted·····-3.48-3.01r-3.48-15.31-48.30
Weighted average shares, basic12,318,8176,279,7445,537,9573,339,9061,469,875r16,746,679····
Weighted average shares, diluted···3,339,9061,469,875r16,746,679····
Weighted average shares, basic and diluted·····16,746,6794,519,201r7,794,489665,605466,024
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton AYTU · research, not advice